Companies: 10,795·Total market cap: $144.5T
Bayer AG

Bayer AG

BAYRYOTCHealthcare● Active
$10.21
$-0.09(-0.85%)
Market Cap$40.1B
P/E Ratio—
52W High$14.85
52W Low$7.19
Cash on HandFinancialsRevenue

Bayer AG (BAYRY) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

BAYRY · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$7.85B▼ -2.9% vs prior year
FY · as of Dec 31, 2025 · Reported in EUR
Cash & Cash Equiv. (CCE)
$6.67B
cashAndCashEquivalents
Short-Term Investments
$1.18B
shortTermInvestments
YoY Change vs Prior Year
-2.9%
vs prior fiscal year
Latest Quarter
$5.73B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in EUR

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$7.85BCash on Hand
Total Debt$37.43BTotal Debt
Net Cash / Net Debt−$29.57BNet Debt Position
Cash vs Debt Ratio
Cash 17%Debt 83%

Bayer AG carries a net debt position of $29.57B. Total debt ($37.43B) exceeds cash on hand ($7.85B). Bayer AG cash vs debt ratio: 17% cash / 83% debt.

Net Cash = Cash & ST Investments − Total Debt$7.85B − $37.43B = −$29.57B

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
BAYRY annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$7.85B-2.9%
Dec 31, 2024$8.09B-23.6%
Dec 31, 2023$10.59B+4.3%
Dec 31, 2022$10.15B+31.2%
Dec 31, 2021$7.74B-34.9%
BAYRY cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.7%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Bayer AG
Bayer AGYOU
BAYRY
$7.85B19.5%
#4
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#5
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Bayer AG (BAYRY) cash on hand as of December 31, 2025 is $7.85B, comprising $6.67B in cash and cash equivalents (CCE) plus $1.18B in short-term investments — reported as Bayer AG cash and short-term investments on the balance sheet (10-K filing). Also referred to as Bayer AG cash reserves or cash position.

Bayer AG annual cash on hand history shows decreased -2.9% in 2025: decreased -2.9% in 2025. Bayer AG cash reserves in 2025 reflect the company's capital allocation strategy.

Bayer AG carries total debt of $37.43B against cash of $7.85B, resulting in a net debt position of -$29.57B. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

BAYRY cash on hand · 5 questions

As of December 31, 2025, Bayer AG (BAYRY) has $7.85B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $6.67B in cash and cash equivalents (CCE) plus $1.18B in short-term investments. Latest quarter (March 31, 2026): $5.73B. Data sourced from the annual 10-K filing via FMP.

BAYRY cash on handBAYRY cash reservesBAYRY cash 2025how much cash does BAYRY have

▸ Source: FMP /balance-sheet-statement · US GAAP · Bayer AG · Bayer AG SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025